Millennium Management
BJDX icon

Millennium Management’s Bluejay Diagnostics BJDX Stock Holding History

Millennium Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– -$12K – 6578
2022
Q3 		– Sell
-1
Closed -$34K – 6604
2022
Q2 		$27K Buy
+1
New +$35.5K ﹤0.01% 6402

Other funds holding BJDX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Millennium Management's BJDX Position: Q4 2022 in Review

Millennium Management held its Bluejay Diagnostics (BJDX) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6578.

Millennium Management first reported a position in BJDX in Q2 2022 and has held it in 1 quarter since. The position peaked at $27K in Q2 2022. 5 funds tracked by Wall St. Rank hold BJDX as of Q4 2022.

  • Millennium Management held 0 shares of Bluejay Diagnostics worth $0 as of Q4 2022.
  • Millennium Management left its Bluejay Diagnostics share count unchanged in Q4 2022.
  • Bluejay Diagnostics made up ﹤0.01% of Millennium Management's portfolio in Q4 2022, its #6578 holding.
  • Millennium Management first reported a position in Bluejay Diagnostics in Q2 2022 and has held it in 1 quarter since.
  • Millennium Management's Bluejay Diagnostics position peaked at $27K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.